<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="under 5 years old. They can lead to complications, super-infection," exact="respiratory failure," post="and even compromised respiratory function in adulthood. For some"/>
 <result pre="highlight the available strategies to reduce the burden of paediatric" exact="respiratory disease." post="The optimal use of influenza, pneumococcal, pertussis and measles"/>
 <result pre="of paediatric respiratory disease. The optimal use of influenza, pneumococcal," exact="pertussis" post="and measles vaccines is required in order to reduce"/>
 <result pre="respiratory disease. The optimal use of influenza, pneumococcal, pertussis and" exact="measles" post="vaccines is required in order to reduce ARI burden."/>
 <result pre="According to estimates made by the World Health Organization (WHO)," exact="pneumonia" post="kills more children worldwide than any other disease, even"/>
 <result pre="other disease, even more than acquired immune deficiency syndrome (AIDS)," exact="malaria" post="and measles combined [9,10,11]. In healthy children, nasopharyngeal colonization"/>
 <result pre="even more than acquired immune deficiency syndrome (AIDS), malaria and" exact="measles" post="combined [9,10,11]. In healthy children, nasopharyngeal colonization with respiratory"/>
 <result pre="are important determinants of bacterial colonization [13,14]. Respiratory viruses including" exact="influenza" post="viruses, respiratory syncytial virus (RSV), human rhinoviruses (HRV), human"/>
 <result pre="children ranges from 1% to 44% [21], and studies on" exact="influenza" post="pandemics over the last 100 years have strengthened the"/>
 <result pre="100 years have strengthened the association of bacterial super-infections and" exact="influenza" post="infections [2,22]. In addition, pertussis and measles still represent"/>
 <result pre="association of bacterial super-infections and influenza infections [2,22]. In addition," exact="pertussis" post="and measles still represent serious medical issues with lower"/>
 <result pre="bacterial super-infections and influenza infections [2,22]. In addition, pertussis and" exact="measles" post="still represent serious medical issues with lower respiratory tract"/>
 <result pre="highlight the available strategies to reduce the burden of paediatric" exact="respiratory disease." post="2. Respiratory Pathogens and Available Vaccines 2.1. Influenza Vaccination"/>
 <result pre="number of medical visits, drug prescriptions, and hospital admissions for" exact="respiratory disease" post="[34,35,36]. Influenza-related complications seem to be more common in"/>
 <result pre="authorities worldwide have long recommended that these children receive the" exact="influenza" post="vaccine every year. However, recently collected data clearly demonstrate"/>
 <result pre="demonstrate that otherwise healthy children can also suffer from severe" exact="influenza" post="and that the annual number of deaths is not"/>
 <result pre="children with chronic severe diseases [34,35]. Every year during the" exact="influenza" post="season, together with the two subtypes of influenza A"/>
 <result pre="during the influenza season, together with the two subtypes of" exact="influenza" post="A virus (A/H1N1 and A/H3N2), two lineages of influenza"/>
 <result pre="of influenza A virus (A/H1N1 and A/H3N2), two lineages of" exact="influenza" post="B viruses (B/Victoria/2/87-like and B/Yamagata/16/88-like) simultaneously circulate; in some"/>
 <result pre="viruses (B/Victoria/2/87-like and B/Yamagata/16/88-like) simultaneously circulate; in some years, the" exact="influenza" post="B viruses are responsible for the major disease burden"/>
 <result pre="viruses are responsible for the major disease burden [37,38,39]. Unlike" exact="influenza" post="A viruses, humans are the sole host with epidemiological"/>
 <result pre="viruses, humans are the sole host with epidemiological relevance for" exact="influenza" post="B viruses. Influenza B viruses evolve mainly through genetic"/>
 <result pre="of the ability to cause disease. Regardless of the lineage," exact="influenza" post="B infection can cause severe disease and death [39]."/>
 <result pre="B infection can cause severe disease and death [39]. During" exact="influenza" post="season, influenza C virus can circulate infecting humans, dogs,"/>
 <result pre="can cause severe disease and death [39]. During influenza season," exact="influenza" post="C virus can circulate infecting humans, dogs, and pigs,"/>
 <result pre="and pigs, sometimes causing severe illness and local epidemics; however," exact="influenza" post="C virus is less common than the other types"/>
 <result pre="C virus is less common than the other types of" exact="influenza" post="viruses and usually it only causes mild disease in"/>
 <result pre="in children. In the past, recommended vaccines included only one" exact="influenza" post="B lineage, chosen by the World Health Organization (WHO)"/>
 <result pre="in the previous year; however, currently, quadrivalent vaccines containing both" exact="influenza" post="B lineages represent the best influenza prevention strategy [40,41,42]."/>
 <result pre="quadrivalent vaccines containing both influenza B lineages represent the best" exact="influenza" post="prevention strategy [40,41,42]. Studies have shown that the administration"/>
 <result pre="the administration of quadrivalent inactivated (IIV) and live attenuated (LAIV)" exact="influenza" post="vaccines to healthy children is effective at reducing the"/>
 <result pre="[43,44,45]. The USA Advisory Committee on Immunization Practices (ACIP) recommends" exact="influenza" post="vaccination for the entire paediatric population, regardless of age"/>
 <result pre="ACIP highlights the importance of administering 1 dose of any" exact="influenza" post="vaccine annually to prevent influenza disease and complications, with"/>
 <result pre="administering 1 dose of any influenza vaccine annually to prevent" exact="influenza" post="disease and complications, with 2 doses separated by at"/>
 <result pre="years who did not receive at least 2 doses of" exact="influenza" post="vaccine before 1 July 2018 [46]. Within Europe, there"/>
 <result pre="July 2018 [46]. Within Europe, there are huge variations in" exact="influenza" post="vaccine recommendations; for example, in Italy, as in some"/>
 <result pre="for example, in Italy, as in some other countries, the" exact="influenza" post="vaccine is recommended only for at-risk people and not"/>
 <result pre="and infants in the first 6 months of life from" exact="influenza" post="is so important that many health authorities have recommended"/>
 <result pre="influenza is so important that many health authorities have recommended" exact="influenza" post="vaccinations of pregnant women [49,50,51]. Studies have shown that"/>
 <result pre="have shown that vaccination during pregnancy is effective in reducing" exact="influenza" post="cases for at least one influenza season [52,53]. Experts"/>
 <result pre="is effective in reducing influenza cases for at least one" exact="influenza" post="season [52,53]. Experts agree that the available influenza vaccines"/>
 <result pre="least one influenza season [52,53]. Experts agree that the available" exact="influenza" post="vaccines can significantly reduce the risk of contracting influenza"/>
 <result pre="available influenza vaccines can significantly reduce the risk of contracting" exact="influenza" post="in healthy or immunocompromised subjects of any age [54]."/>
 <result pre="in healthy or immunocompromised subjects of any age [54]. Preventing" exact="influenza" post="infection through vaccination may decrease the subsequent burden of"/>
 <result pre="the bacterial pathogens, reduce hospitalizations, and reduce antibiotic prescriptions for" exact="influenza" post="complications in children and adolescents [55,56]. Moreover, a reduction"/>
 <result pre="complications in children and adolescents [55,56]. Moreover, a reduction in" exact="influenza" post="cases can have an impact on the abuse of"/>
 <result pre="and invasive infections in children and adults, most commonly acute" exact="otitis media" post="(AOM), community-acquired pneumonia (CAP), and invasive pneumococcal diseases (IPD),"/>
 <result pre="children and adults, most commonly acute otitis media (AOM), community-acquired" exact="pneumonia" post="(CAP), and invasive pneumococcal diseases (IPD), such as bacteraemia"/>
 <result pre="(CAP), and invasive pneumococcal diseases (IPD), such as bacteraemia and" exact="meningitis" post="[60,61,62,63,64]. In the late 1970s, a 14-valent Pneumococcal Polysaccharide"/>
 <result pre="use one over the other [70]. 2.3. Pertussis Vaccination Bordetella" exact="pertussis" post="is a Gram-negative coccobacillus that causes whooping cough and"/>
 <result pre="[73,74]. There has been an increase in the incidence of" exact="pertussis" post="in the European Union from 2011 onwards [75]. The"/>
 <result pre="the European Union from 2011 onwards [75]. The resurgence of" exact="pertussis" post="observed in recent years seems to be a complex"/>
 <result pre="to a number of reasons, including the use of acellular" exact="pertussis" post="(aP) vaccines in many locales. Lack of mucosal immune"/>
 <result pre="earlier waning of protective immunity and the circulation of B." exact="pertussis" post="variants depleted of vaccine-included antigens further favor the increase"/>
 <result pre="variants depleted of vaccine-included antigens further favor the increase in" exact="pertussis" post="disease [74]. Studies in immunized children have reported that"/>
 <result pre="and protective immunity wane 3–5 years after immunization with acellular" exact="pertussis" post="(aP) vaccines, which may reflect poor induction of memory"/>
 <result pre="years during adulthood [79,80]. Recently, in several countries vaccination against" exact="pertussis" post="in the 2nd and 3rd vaccination during pregnancy is"/>
 <result pre="3rd vaccination during pregnancy is recommended in order to prevent" exact="pertussis" post="in the first 6 months of life [81,82]. Studies"/>
 <result pre="months of life [81,82]. Studies showed &amp;gt; 90% effectiveness of" exact="pertussis" post="vaccination of mothers against pertussis in the first 6"/>
 <result pre="showed &amp;gt; 90% effectiveness of pertussis vaccination of mothers against" exact="pertussis" post="in the first 6 months of life. Vaccine administration"/>
 <result pre="for both mother and foetus [81,82]. In conclusion, prevention of" exact="pertussis" post="with currently available vaccines reaching high vaccination coverage rates"/>
 <result pre="colonization, and transmission. However, present knowledge seems to indicate that" exact="pertussis" post="toxin, particularly if genetically detoxified, represents the main antigen"/>
 <result pre="protection from disease even if not from infection. The optimal" exact="pertussis" post="vaccine would be one that induces both mucosal and"/>
 <result pre="lead to severe complications, which can deeply impact children, and" exact="pneumonia" post="represents one of the most common [84,85]. It is"/>
 <result pre="for more than 100,000 deaths every year [84,85]. Although the" exact="measles" post="vaccine was introduced in national vaccination schedules in the"/>
 <result pre="[86,87]. Every month, despite the availability of the vaccine, many" exact="measles" post="cases continue to be reported worldwide, with episodic clusters."/>
 <result pre="of 2019 through May [86]. In Europe, twenty-seven countries reported" exact="measles" post="data for March 2019, with 1,548 cases reported by"/>
 <result pre="importance of maintaining high vaccination coverage with two doses of" exact="measles" post="vaccine administered in the first years of life, the"/>
 <result pre="life [90]. Prematurity, low birth weight, male sex, broncho-pulmonary dysplasia," exact="congenital heart disease," post="immunodeficiency, cerebral palsy, and Down’s syndrome are risk factors"/>
 <result pre="[90]. Prematurity, low birth weight, male sex, broncho-pulmonary dysplasia, congenital" exact="heart disease," post="immunodeficiency, cerebral palsy, and Down’s syndrome are risk factors"/>
 <result pre="birth weight, male sex, broncho-pulmonary dysplasia, congenital heart disease, immunodeficiency," exact="cerebral palsy," post="and Down’s syndrome are risk factors for severe RSV"/>
 <result pre="under 5 years old. They can lead to complications, super-infection," exact="respiratory failure," post="and even compromised respiratory function in adulthood. For some"/>
 <result pre="about vaccines against respiratory pathogens. The use of influenza, pneumococcal," exact="pertussis" post="and measles vaccines is essential to reduce ARIs burden."/>
 <result pre="against respiratory pathogens. The use of influenza, pneumococcal, pertussis and" exact="measles" post="vaccines is essential to reduce ARIs burden. Vaccination coverage"/>
 <result pre="Dis.2004414415410.1016/S1473-3099(04)00938-714998500 13.NairH.BrooksW.A.KatzM.RocaA.BerkleyJ.A.MadhiS.A.SimmermanJ.M.GordonA.SatoM.HowieS.et al.Global burden of respiratory infections due to seasonal" exact="influenza" post="in young children: A systematic review and meta-analysisLancet20113781917193010.1016/S0140-6736(11)61051-922078723 14.VerhagenL.M.LuesinkM.WarrisA.de"/>
 <result pre="the Emergency DepartmentCochrane Database Syst. Rev.20141500645210.1002/14651858.CD006452.pub4 16.BashirU.NisarN.ArshadY.AlamM.M.AshrafA.SadiaH.KaziB.M.ZaidiS.S.Respiratory syncytial virus and" exact="influenza" post="are the key viral pathogens in children &amp;lt;2 years"/>
 <result pre="the key viral pathogens in children &amp;lt;2 years hospitalized with" exact="bronchiolitis" post="and pneumonia in Islamabad PakistanArch Virol.201716276377327885562 17.García-GarcíaM.L.CalvoC.ReyC.DíazB.MolineroM.D.PozoF.CasasI.Human metapnuemovirus infections"/>
 <result pre="viral pathogens in children &amp;lt;2 years hospitalized with bronchiolitis and" exact="pneumonia" post="in Islamabad PakistanArch Virol.201716276377327885562 17.García-GarcíaM.L.CalvoC.ReyC.DíazB.MolineroM.D.PozoF.CasasI.Human metapnuemovirus infections in hospitalized"/>
 <result pre="viral respiratory infectionExpert Rev. Anti Infect. Ther.20121090991610.1586/eri.12.8023030330 22.McCullersJ.A.The co-pathogenesis of" exact="influenza" post="viruses with bacteria in the lungNat. Rev. Microbiol.20141225226210.1038/nrmicro323124590244 23.McCarthyN.L.GeeJ.SukumaranL.WeintraubE.DuffyJ.KharbandaE.O.BaxterR.IrvingS.KingJ.DaleyM.F.et"/>
 <result pre="26.EspositoS.PrincipiN.Influenza vaccination in pediatric ageExpert. Rev. Vaccines20151478578710.1586/14760584.2015.103729025872557 27.AntonovaE.N.RycroftC.E.AmbroseC.S.HeikkinenT.PrincipiN.Burden of paediatric" exact="influenza" post="in Western Europe: A systematic reviewBMC Public Health20121296810.1186/1471-2458-12-96823146107 28.EspositoS.MencacciA.CenciE.CamilloniB.SilvestriE.PrincipiN.Multiplex"/>
 <result pre="Practice?Front. Cell. Infect. Microbiol.2019919610.3389/fcimb.2019.0019631275863 29.LafondK.E.NairH.RasoolyM.H.ValenteF.BooyR.RahmanM.KitsutaniP.YuH.GuzmanG.CoulibalyD.et al.Global role and burden of" exact="influenza" post="in pediatric respiratory hospitalizations, 1982–2012: A systematic analysisPLoS Med.201613e100197710.1371/journal.pmed.100197727011229"/>
 <result pre="analysisPLoS Med.201613e100197710.1371/journal.pmed.100197727011229 30.HeikkinenT.SilvennoinenH.HeinonenS.VuorinenT.Clinical and socioeconomic impact of moderate-to-severe versus mild" exact="influenza" post="in childrenEur. J. Clin. Microbiol. Infect. Dis.2016351107111310.1007/s10096-016-2641-927086364 31.PrincipiN.EspositoS.Protection of"/>
 <result pre="in influenza-like illnessesPediatrics201413468469010.1542/peds.2014-0505 35.NakamuraS.DavisK.M.WeiserJ.N.Synergistic stimulation of type I interferons during" exact="influenza" post="virus coinfection promotes Streptococcus pneumoniae colonization in miceJ. Clin."/>
 <result pre="epidemic profile: A key role for mathematical modellingPLoS Pathog.201814e100677010.1371/journal.ppat.100677029447284 37.PrincipiN.EspositoS.Severe" exact="influenza" post="in children: Incidence and risk factorsExpert Rev. Anti Infect."/>
 <result pre="and socioeconomic impact of different types and subtypes of seasonal" exact="influenza" post="viruses in children during influenza seasons 2007/2008 and 2008/2009BMC"/>
 <result pre="types and subtypes of seasonal influenza viruses in children during" exact="influenza" post="seasons 2007/2008 and 2008/2009BMC Infect. Dis.20111127110.1186/1471-2334-11-27121992699 39.EspositoS.CantaruttiL.MolteniC.G.DalenoC.ScalaA.TagliabueC.PelucchiC.GiaquintoC.PrincipiN.Clinical manifestations and"/>
 <result pre="and 2008/2009BMC Infect. Dis.20111127110.1186/1471-2334-11-27121992699 39.EspositoS.CantaruttiL.MolteniC.G.DalenoC.ScalaA.TagliabueC.PelucchiC.GiaquintoC.PrincipiN.Clinical manifestations and socio-economic impact of" exact="influenza" post="among healthy children in the communityJ. Infect.20116237938710.1016/j.jinf.2011.02.01521414357 40.PirallaA.LunghiG.RuggieroL.GirelloA.BianchiniS.RovidaF.CaimmiS.MarsegliaG.L.PrincipiN.BaldantiF.et al.Molecular"/>
 <result pre="healthy children in the communityJ. Infect.20116237938710.1016/j.jinf.2011.02.01521414357 40.PirallaA.LunghiG.RuggieroL.GirelloA.BianchiniS.RovidaF.CaimmiS.MarsegliaG.L.PrincipiN.BaldantiF.et al.Molecular epidemiology of" exact="influenza" post="B virus among hospitalized pediatric patients in Northern Italy"/>
 <result pre="during the 2015-16 seasonPLoS ONE201712e018589310.1371/journal.pone.018589329049310 41.EspositoS.100 years since the 1918" exact="influenza" post="pandemicHum. Vaccin. Immunother.20181450450710.1080/21645515.2018.144659129553916 42.ChongY.IkematsuH.Is seasonal vaccination a contributing factor"/>
 <result pre="42.ChongY.IkematsuH.Is seasonal vaccination a contributing factor to the selection of" exact="influenza" post="epidemic variants?Hum. Vaccin. Immunother.20181451852210.1080/21645515.2017.137322828857677 43.TreanorJ.J.TalbotH.K.OhmitS.E.ColemanL.A.ThompsonM.G.ChengP.Y.PetrieJ.G.LofthusG.MeeceJ.K.WilliamsJ.V.et al.US Flu-VE Network. Effectiveness"/>
 <result pre="variants?Hum. Vaccin. Immunother.20181451852210.1080/21645515.2017.137322828857677 43.TreanorJ.J.TalbotH.K.OhmitS.E.ColemanL.A.ThompsonM.G.ChengP.Y.PetrieJ.G.LofthusG.MeeceJ.K.WilliamsJ.V.et al.US Flu-VE Network. Effectiveness of seasonal" exact="influenza" post="vaccines in the United States during a season with"/>
 <result pre="Acute Lung Injury and Sepsis Investigators (PALISI) Network. Effectiveness of" exact="influenza" post="vaccine against life-threatening RT-PCR-confirmed influenza illness in US children,"/>
 <result pre="Investigators (PALISI) Network. Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed" exact="influenza" post="illness in US children, 2010–2012J. Infect. Dis.201421067468310.1093/infdis/jiu18524676207 45.PrincipiN.SenatoreL.EspositoS.Protection of"/>
 <result pre="US children, 2010–2012J. Infect. Dis.201421067468310.1093/infdis/jiu18524676207 45.PrincipiN.SenatoreL.EspositoS.Protection of young children from" exact="influenza" post="through universal vaccinationHum. Vaccin. Immunother.2015112350235810.1080/21645515.2015.105542826090704 46.Centers for Disease Control"/>
 <result pre="49.PoehlingK.A.SzilagyiP.G.StaatM.A.SnivelyB.M.PayneD.C.BridgesC.B.ChuS.Y.LightL.S.PrillM.M.FinelliL.et al.New Vaccine Surveillance Network. Impact of maternal immunization on" exact="influenza" post="hospitalizations in infantsAm. J. Obstet. Gynecol.201120414114810.1016/j.ajog.2011.02.042 50.EickA.A.UyekiT.M.KlimovA.HallH.ReidR.SantoshamM.O’BrienK.L.Maternal influenza vaccination"/>
 <result pre="immunization on influenza hospitalizations in infantsAm. J. Obstet. Gynecol.201120414114810.1016/j.ajog.2011.02.042 50.EickA.A.UyekiT.M.KlimovA.HallH.ReidR.SantoshamM.O’BrienK.L.Maternal" exact="influenza" post="vaccination and effect on influenza virus infection in young"/>
 <result pre="infantsAm. J. Obstet. Gynecol.201120414114810.1016/j.ajog.2011.02.042 50.EickA.A.UyekiT.M.KlimovA.HallH.ReidR.SantoshamM.O’BrienK.L.Maternal influenza vaccination and effect on" exact="influenza" post="virus infection in young infantsArch. Pediatr. Adolesc. Med.201116510411110.1001/archpediatrics.2010.19220921345 51.NunesM.C.CutlandC.L.JonesS.DownsS.WeinbergA.OrtizJ.R.NeuzilK.M.SimõesE.A.F.KlugmanK.P.MadhiS.A.Efficacy"/>
 <result pre="from a Randomized Controlled TrialClin. Infect. Dis.2017651066107110.1093/cid/cix49728575286 52.ZamanK.RoyE.ArifeenS.E.RahmanM.RaqibR.WilsonE.OmerS.B.ShahidN.S.BreimanR.F.SteinhoffM.C.Effectiveness of maternal" exact="influenza" post="immunization in mothers and infantsN. Engl. J. Med.20083591555156410.1056/NEJMoa070863018799552 53.EspositoS.BosisS.MorlacchiL.BaggiE.SabatiniC.PrincipiN.Can"/>
 <result pre="Pathogens of the Respiratory TractFront. Immunol.20189270010.3389/fimmu.2018.0270030515172 55.KnightG.M.ClarksonM.de SilvaT.I.Potential impact of" exact="influenza" post="vaccine roll-out on antibiotic use in AfricaJ. Antimicrob. Chemother.2018732197220010.1093/jac/dky17229746637"/>
 <result pre="Restrict Their Use?PLoS Biol.201513e100226610.1371/journal.pbio.100226626444324 57.RufB.R.KnufM.The burden of seasonal and pandemic" exact="influenza" post="in infants and childrenEur. J. Pediatr.201417326527610.1007/s00431-013-2023-623661234 58.EspositoS.PrincipiN.Different influenza vaccine"/>
 <result pre="and pandemic influenza in infants and childrenEur. J. Pediatr.201417326527610.1007/s00431-013-2023-623661234 58.EspositoS.PrincipiN.Different" exact="influenza" post="vaccine formulations and adjuvants for childhood influenza vaccinationVaccine2011297535754110.1016/j.vaccine.2011.08.01221820478 59.PrincipiN.Di"/>
 <result pre="J. Pediatr.201417326527610.1007/s00431-013-2023-623661234 58.EspositoS.PrincipiN.Different influenza vaccine formulations and adjuvants for childhood" exact="influenza" post="vaccinationVaccine2011297535754110.1016/j.vaccine.2011.08.01221820478 59.PrincipiN.Di CaraG.BizzarriI.IsidoriC.BorgiaP.MigniniC.SaponaraM.ArgentieroA.EspositoS.Prevention of Invasive Pneumococcal Disease: Problems Emerged"/>
 <result pre="and 13-Valent vaccines similar?Future Microbiol.201992192310.2217/fmb-2019-015131373218 71.Argondizo-CorreiaC.RodriguesA.K.S.de BritoC.A.Neonatal Immunity to Bordetella" exact="pertussis" post="Infection and Current Prevention StrategiesJ. Immunol. Res.20192019713416810.1155/2019/713416830882004 72.PrincipiN.LittD.TerranovaL.PiccaM.MalvasoC.VitaleC.FryN.K.EspositoS.The Italian"/>
 <result pre="Pertussis-associated persistent cough in previously vaccinated childrenJ. Med. Microbiol.2017661699170210.1099/jmm.0.00060728984566 73.MelvinJ.A.SchellerE.V.MillerJ.F.CotterP.A.Bordetella" exact="pertussis" post="pathogenesis: Current and future challengesNat. Rev. Microbiol.20141227428810.1038/nrmicro323524608338 74.PolinoriI.EspositoS.Clinical Findings"/>
 <result pre="Serum Antibodies and Memory B CellsFront. Immunol.20178115810.3389/fimmu.2017.0115828966622 77.KauhlB.HeilJ.HoebeC.J.SchweikartJ.KrafftT.Dukers-MuijrersN.H.Is the current" exact="pertussis" post="incidence only the results of testing? A spatial and"/>
 <result pre="the results of testing? A spatial and space-time analysis of" exact="pertussis" post="surveillance data using cluster detection methods and geographically weightedregression"/>
 <result pre="weightedregression modellingPLoS ONE201712e017238310.1371/journal.pone.017238328278180 78.WilkM.M.BorknerL.MisiakA.CurhamL.AllenA.C.MillsK.H.G.Immunization with whole cell but not acellular" exact="pertussis" post="vaccines primes CD4 TRM cells that sustain protective immunity"/>
 <result pre="PertussisAvailable online: http://vaccine-schedule.ecdc.europa.eu/pages/scheduler.aspx(accessed on 22 May 2019) 81.AmirthalingamG.AndrewsN.CampbellH.RibeiroS.KaraE.DoneganK.FryN.K.MillerE.RamsayM.Effectiveness of maternal" exact="pertussis" post="vaccination in England: An observational studyLancet20143841521152810.1016/S0140-6736(14)60686-325037990 82.RomaninV.AcostaA.M.JuarezM.D.V.BriereE.SanchezS.M.CordobaB.L.SevillaM.E.LucionM.F.UrrutiaA.SagradiniS.et al.Maternal Vaccination"/>
</results>
